1 – 33 of 33
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2021
-
Mark
The immune landscape of colorectal cancer
(
- Contribution to journal › Article
-
Mark
Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
- 2020
-
Mark
Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version
(
- Contribution to journal › Article
-
Mark
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
(
- Contribution to journal › Article
- 2017
-
Mark
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III) : A multicentre, randomised, non-blinded, phase 3, non-inferiority trial
(
- Contribution to journal › Article
-
Mark
A pathology atlas of the human cancer transcriptome
(
- Contribution to journal › Article
-
Mark
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4) : A multicentre, open-label, randomised, phase 3 trial
(
- Contribution to journal › Article
- 2016
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
(
- Contribution to journal › Article
- 2015
-
Mark
The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
(
- Contribution to journal › Article
-
Mark
A template for writing radiotherapy protocols.
(
- Contribution to journal › Article
- 2014
-
Mark
Acta Oncologica and a new generation of scientists in oncology
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
(
- Contribution to journal › Article
-
Mark
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.
(
- Contribution to journal › Article
- 2013
-
Mark
Validation of the Distress Thermometer in a Swedish population of oncology patients; accuracy of changes during six months
(
- Contribution to journal › Article
-
Mark
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
(
- Contribution to journal › Article
- 2012
-
Mark
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.
(
- Contribution to journal › Article
- 2011
-
Mark
Particle Therapy - A next logical step in the improvement of radiotherapy
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas.
(
- Contribution to journal › Article
- 2010
-
Mark
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
(
- Contribution to journal › Article
-
Mark
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
(
- Contribution to journal › Article
-
Mark
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
(
- Contribution to journal › Letter
- 2009
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
(
- Contribution to journal › Article
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
- 2005
-
Mark
The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
(
- Contribution to journal › Article
-
Mark
The potential of proton beam radiation therapy in gastrointestinal cancer.
(
- Contribution to journal › Article
-
Mark
The potential of proton beam radiation therapy in head and neck cancer.
(
- Contribution to journal › Article
- 2003
-
Mark
Early and intermediate stage Hodgkin's lymphoma - report from the Swedish National Care Programme.
(
- Contribution to journal › Article
- 2002
-
Mark
Swedish Cancer Society radiation therapy research investigation.
(
- Contribution to journal › Article
-
Mark
Riktlinjer för handläggning av patienter med pankreascancer
(
- Contribution to journal › Article